Honey Bee Gut Phages May Be Essential for Pollinator Health and Microbial Stability

-

A large-scale European metagenomic study has revealed that the honey bee gut contains a remarkably diverse and previously unexplored population of bacteriophages, suggesting that these viruses may play a far more important role in pollinator biology than previously understood. While most research on honey bee health has traditionally focused on bacterial pathogens, pesticides, parasites, and habitat decline, the new findings indicate that bacteriophages could represent a major ecological component influencing microbial balance, stress adaptation, and colony resilience.

The Phage Therapy

To investigate the viral ecosystem associated with honey bees, researchers analyzed 450 virus-enriched gut samples collected from bee populations across eight European countries. The study examined multiple gut compartments and seasonal variations, generating one of the most comprehensive datasets ever produced for the analysis of insect-associated phages. Sequencing identified more than 2,300 non-redundant phage genomes, most of which showed little or no similarity to previously known viral sequences. Researchers also identified over one hundred potentially novel Caudoviricetes orders, highlighting the immense hidden diversity of bacteriophages within insect microbiomes.

One of the most striking discoveries was the existence of a conserved “core phageome” composed of 97 bacteriophages consistently detected across all sampled countries. These same phages were also found in independent datasets originating from Europe, China, and the United States, suggesting that some bacteriophages may be globally associated with the honey bee gut ecosystem regardless of geography or environmental conditions.

The majority of these phages appear to infect bacterial genera that are already known to be essential for honey bee physiology, including Gilliamella, Snodgrassella, Lactobacillus, and Bifidobacterium. These bacterial symbionts contribute to nutrient metabolism, immune modulation, protection against pathogens, and detoxification processes within the bee gut. Importantly, many of the identified phages seem to adopt a temperate lifestyle, integrating into bacterial genomes rather than immediately lysing their hosts. This type of long-term interaction may allow phages to influence bacterial metabolism and ecological fitness over extended periods.

Researchers also identified several auxiliary metabolic genes encoded by the phages themselves. Among the most notable was PAPS reductase, an enzyme involved in sulfur metabolism and oxidative stress regulation. Phages carrying this gene were strongly associated with beneficial bacterial populations, suggesting that they may contribute indirectly to microbiome stability and stress adaptation.

Environmental analysis revealed another important pattern. The abundance of sulfur-metabolism-associated phages declined significantly in agricultural landscapes characterized by intensive pesticide exposure and high cropland density. At the same time, pathogenic viruses such as deformed wing virus became more prevalent in those environments. These observations suggest that environmental stressors may alter not only bacterial communities within bees, but also the phage populations regulating those communities.

The findings challenge the traditional perception of bacteriophages as simple bacterial predators. Instead, the study supports the idea that phages may function as ecological regulators capable of shaping microbial stability, metabolic interactions, and potentially even host health outcomes. In the honey bee gut, bacterial symbionts, phages, and the insect host itself appear to form a tightly interconnected evolutionary system.

Beyond pollinator biology, the work also illustrates the growing power of metagenomics and modern computational biology to uncover previously invisible viral ecosystems. As global concerns surrounding pollinator decline continue to intensify, understanding the hidden microbial networks that sustain colony health may become increasingly important for both agriculture and environmental conservation.

Source: https://doi.org/10.1038/s41467-026-72757-2

Comments

Post a Comment

Most Consulted Articles

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

-
Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

The Phage Therapy in the spotlight !

-
Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Groundbreaking achievement : Phagos raises €25m to end bacterial disease

-
Image
 Phagos raises €25m to end bacterial disease  The company holds the first authorization to market personalized veterinary phage-based treatments on EU soil  ● Founded in 2021, Phagos is ushering in a new era in the fight against bacterial disease with bacteriophages, a powerful alternative to antibiotics. Thanks to an unprecedented regulatory breakthrough and a discovery platform combining microbiology and AI, Phagos offers the first phage-based drugs for veterinary use, a market worth tens of billions of dollars. The company plans to expand further as phage therapy becomes accepted in human health.                              ● The funding round was co-led by CapAgro, Hoxton Ventures, CapHorn, and Demeter alongside Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F.  ● Objectives: deploy veterinary treatments in the field, develop the next generation of pat...
Read more

EMA : Guideline on quality aspects of phage therapy medicinal products

-
Image
The European Medicines Agency Publishes Draft Guideline on Quality Aspects of Phage Therapy Medicinal Products: A Landmark in the Regulation of Bacteriophage Therapeutics Introduction On 16 October 2025 , the European Medicines Agency (EMA) , through its Committee for Medicinal Products for Human Use (CHMP) and the Biologics Working Party (BWP) , adopted for public consultation the draft Guideline on Quality Aspects of Phage Therapy Medicinal Products (EMA/CHMP/BWP/1/2024) . This 15-page document represents the first comprehensive regulatory framework in the European Union specifically addressing the quality, manufacturing, and control requirements for bacteriophage-based medicinal products intended for human use. The release of this draft guideline is a significant milestone in the development of phage therapy as a legitimate, standardised, and potentially widely accessible treatment modality for bacterial infections, particularly in the context of the global antimicrobial resi...
Read more

EUCAST creates a Subcommittee on Phage susceptibility testing

-
Image
Subcommittee on Phage susceptibility testing Lytic bacteriophages, or phages, are viruses that infect and kill bacteria. Phage therapy is emerging as a promising adjuvant to traditional antimicrobials for combatting difficult-to-treat bacterial infections. However, implementation of phage-based treatments requires standardized methods for testing their efficacy to select the optimal therapeutic phages. To address this, EUCAST has established the EUCAST Phage Susceptibility Testing (PST) Subcommittee Remit of the PST Subcommittee : - Developing  standardized reference methods  to ensure uniform and reproducible  in vitro  phage susceptibility testing across laboratories worldwide, - Establishing  criteria for interpretation of PST results , providing clinicians and researchers with evidence-based guidelines to assess phage efficacy and monitor phage activity. - Promoting  quality assurance  by implementing stringent  quality control  measures ...
Read more